Intrepida Bio

Intrepida Bio is a company that develops medicines intended to modulate the innate immune system to fight cancer and other diseases. The company designs proprietary monoclonal antibodies that block the novel targets and its receptor as well as thwart their ability to create a favorable environment for tumor growth, enabling patients to get innovative treatments to cure cancer.